Fresenius Medical Care AG business relationships

Companies named in Fresenius Medical Care AG’s 20-F filed 2026-02-24, and public companies whose annual reports name Fresenius Medical Care AG. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 6.1 / 10
AI naming: 100 / 100
Agent readiness: 30 / 100
AI adoption: 0 / 100

Named in Fresenius Medical Care AG’s annual report 4

PFIZER INC (PFE)Licensor7.7
“Retacrit ® is licensed from Pfizer Inc. since 2015 for certain channels, primarily comprising the U.S. non-hospital dialysis market and nephrology office practices.” SEC filing
Uber Technologies, Inc (UBER)Partner7.7
“For instance, our Fresenius Kidney Care team in the U.S. piloted a program with Uber Health, LLC, (hereinafter referred to as Uber Health) and expanded the partnership nationwide in 2025.” SEC filing
OPKO HEALTH, INC. (OPK)Licensor6.1
“VFMCRP has an exclusive license agreement with OPKO Health, Inc., to co-develop and commercialize Rayaldee ® in Europe (except Russia), Canada, Australia and Japan.” SEC filing
Humacyte, Inc. (HUMA)Supplier5.4
“...assets primarily include receivables related to a royalty stream that the Company is entitled to base on sales made by Humacyte, Inc. in the U.S., vendor and supplier rebates, lease receivables, notes receivable, receivables related to consent agreement on certain pharmaceuticals as well as deposit...” SEC filing

Companies whose annual reports name Fresenius Medical Care AG 5

Cytosorbents Corp (CTSO)names it as partner5.4
“In August 2022, we expanded our partnership with Fresenius Medical Care to a global marketing collaboration.” SEC filing
Humacyte, Inc. (HUMA)names it as distributor5.4
“Under the distribution agreement, Fresenius Medical Care has the exclusive right to sell and distribute the distribution product in the field outside of the United States.” SEC filing
Humacyte, Inc. (HUMA)names it as partner5.4
“our expectations regarding our strategic partnership with Fresenius Medical Care Holdings, Inc. ("Fresenius Medical Care") to sell, market and distribute our 6 millimeter ATEV for certain specified indications and in specified markets, if approved by regulatory authorities;” SEC filing
SeaStar Medical Holding Corp (ICU)names it as supplier5.4
“Fresenius Medical Care North America ("FMCNA") is the current supplier of the cartridges used in our SCD.” SEC filing
Akebia Therapeutics, Inc. (AKBA)names it as licensor4.6
“The Vifor License Agreement granted CSL Vifor an exclusive license to sell Vafseo to Fresenius Medical Care North America and its affiliates, including Fresenius Kidney Care Group LLC, to certain third-party dialysis organizations approved by us, to independent dialysis organizations that are member...” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.